NIDDK Funding Opportunity

DP3 Type 1 Diabetes Targeted Research Award

Research Using Subjects From Selected Type 1 Diabetes Clinical Studies (Living Biobank) (DP3)

This FOA invites applications for ancillary studies that use subjects enrolled in (or screened for participation in) the Type 1 Diabetes TrialNet clinical trials network, OR for ancillary studies that use subjects enrolled in the Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC). Studies are expected to generate scientific discoveries on disease mechanisms, disease pathogenic processes, and biomarkers of disease progression or clinical responses, or complications of type 1 diabetes. This FOA is not intended to fund clinical trials with endpoints for clinical efficacy (including but not limited to C-peptide preservation).

Full AnnouncementPAR-14-064
Open Date3/10/2014
Letter of Intent Due Date
March 10, 2014
Application Due Date
April 10, 2014, by 5:00 PM local time of applicant organization.
NIDDK Program ContactCatherine C. Cowie, Ph.D., MPH 

Print Page

Click outside of the light box to close the box.